经前情感障碍证中西医分型探讨  

Discussion on Classification of Premenstrual Dysphoric Disorder in TCM and Western Medicine

作　　者：高明周[1,2] 杨焕新 刘欢[2] 张浩 高冬梅 GAO Mingzhou;YANG Huanxin;LIU Huan;ZHANG Hao;GAO Dongmei(Doctoral student of 2017 in Shandong University of Traditional Chinese Medicine, Jinan 250355, Shandong, China;Institute of Basic Theory of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250355, China;Qilu University of Technology, Shandong, Jinan 250355, China)

机构地区：[1]山东中医药大学,山东济南250355 [2]山东中医药大学中医基础理论研究所,山东济南250355 [3]齐鲁工业大学,山东济南250355

出　　处：《中华中医药学刊》2018年第7期1587-1590,共4页Chinese Archives of Traditional Chinese Medicine

基　　金：国家自然科学基金面上项目(81473558);国家自然科学基金青年科学基金项目(81001484,81202616,8170141343);山东省自然科学基金培养基金项目(ZR201702140337);山东省青少年教育科学规划项目(18BSH326)

摘　　要：经前情感障碍证在育龄女性中发病率持续走高,因其对于女性患者情绪等的异常影响,相伴的自杀发生率正引起社会的普遍关注。而一线治疗药物氟西汀已被证实存在疗效差异性,辅证此病可能存在不同的发病机制和调节中枢。然中西医体系不同,中医各家亦有不同。可惜的是,国内外目前尚无一致公认的划分依据,致使临床用药缺乏针对性。以PMDD药物疗效差异作为切入点,对于PMDD分型必要性和如何分型做出简要探讨,以期指导临床。Incidence rate of premenstrual dysphoric disorder in women of childbearing age continued to rise,due to the females＇ abnormal emotions. The accompanied incidence of suicide is causing widespread concern in society. The first-line treatment with fluoxetine has been confirmed the existence of differences in efficacy. The secondary evidence of the disease may be different pathogenesis and regulation center. However,Chinese and Western medicine belongs to different systems. Unfortunately,there is no widely recognized at home and abroad on the basis of the division,resulting in the lack of specific clinical use. In this paper,PMDD differences in drug efficacy as an entry point,it briefly discussed PMDD typing necessity and how to make the parting.

关 键 词：PMDD 疗效差异 DSM-5 证候 亚型 

分 类 号：R271.115[医药卫生—中医妇科学]